Skip to Content

Month: February 2023

Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says

By Janelle Chavez, CNN Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday. The cases were confirmed in

Continue Reading

Berkshire Hathaway earnings fall 8% in fourth quarter but rise 12% for full year

By Ramishah Maruf, CNN Berkshire Hathaway’s operating earnings fell during the fourth quarter of 2022, as inflation pressures and high interest rates bogged down businesses at the company run by investor Warren Buffett, though the full year profits reached a “record.” Berkshire’s operating profit, or the total profit from core operations before tax and interest,

Continue Reading
Skip to content